 |
Lamictal Chewable Dispersible Tablets (Lamotrigine)
Company: Glaxo Wellcome, Inc.
Application No.: 020-764 & 020-241/S002
Approval Date: 8/24/1998
Back to Drug Approval Page
PDF requires the free Adobe
Acrobat Reader
Date created: March 30, 2001; last updated: July 1, 2005 |
 |